Lewis Gryziewicz, Pharm.D.
Vice President, Regulatory Affairs
Lewis Gryziewicz, PharmD joined AnaptysBio in January 2019 with more than 30 years of experience in Regulatory Affairs and Research and Development. Prior to joining AnaptysBio, Lewis has worked at various pharmaceutical companies including Acadia Pharmaceuticals, Quark Pharmaceuticals, Allergan and Johnson & Johnson. He has been a key player in the global approvals of OZURDEX®, COMBIGAN®, LUMIGAN®, LUMIGAN® PF UD, ALPHAGAN® P, GANFORT® PF UD, RENOVA®, RETIN-A® MICRO, ORTHO CEPT® and ORTHO TRI-CYCLEN®. Lewis received his Doctor of Pharmacy degree from the University of Colorado, Masters in Business Administration from Fairleigh Dickinson University, and Bachelor of Science in Pharmacy from the University of the Sciences in Philadelphia.